Journal article
Integrated pharmacodynamic analysis identifies two metabolic adaption pathways to metformin in breast cancer
- Abstract:
-
Late-phase clinical trials investigating metformin as a cancer therapy are underway. However, there remains controversy as to the mode of action of metformin in tumors at clinical doses. We conducted a clinical study integrating measurement of markers of systemic metabolism, dynamic FDG-PET-CT, transcriptomics, and metabolomics at paired time points to profile the bioactivity of metformin in primary breast cancer. We show metformin reduces the levels of mitochondrial metabolites, activates mu...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Engineering and Physical Sciences Research Council
More from this funder
NIHR Oxford Biomedical Research Centre
More from this funder
Breast Cancer Research Foundation
More from this funder
Bibliographic Details
- Publisher:
- Cell Press Publisher's website
- Journal:
- Cell Metabolism Journal website
- Volume:
- 28
- Issue:
- 5
- Pages:
- 679-688.e4
- Publication date:
- 2018-09-20
- Acceptance date:
- 2018-08-24
- DOI:
- ISSN:
-
1550-4131
- Pmid:
-
30244975
- Source identifiers:
-
864243
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:864243
- UUID:
-
uuid:a9320331-ae91-42bb-bc6d-1fcd4384e020
- Local pid:
- pubs:864243
- Deposit date:
- 2018-12-03
Terms of use
- Copyright holder:
- Crown Copyright
- Copyright date:
- 2018
- Notes:
-
Crown Copyright © 2018 Published by Elsevier Inc.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record